RQ Bio
London, United States · Founded 2021 · $115.0M raised
- Headquarters
- London
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- rqbio.com
- Total Funding
- $115.0M
- Last Round
- $115.0M Venture RoundJun 2026
- Rounds
- 1
About
RQ Bio (RQ Biotechnology Ltd.) is a London-based clinical-stage biotechnology company focused on developing preventative antibody-based medicines for infectious diseases. Its lead program RQB01 is a long-acting, broad-spectrum antibody therapeutic designed to provide season-long protection against seasonal influenza in high-risk patient populations, currently in preclinical development.
Summary
RQ Bio is a Biotech company based in London, United States, founded in 2021. It has raised $115.0M in total across 1 round, most recently a $115.0M Venture Round round in Jun 2026.
Funding History
Jun 2026
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rq-bio"><img src="https://indexed.vc/api/badge/company/rq-bio" alt="RQ Bio on Indexed.vc" width="260" height="76" /></a>